Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Lancet Glob Health. 2020 Feb;8(2):e296–e304. doi: 10.1016/S2214-109X(19)30527-3

Table 3:

Sensitivity, specificity positive and negative predictive values, and screen-positive rates by HIV status utilizing different cycle threshold (Ct) cut-offs from the three channels on HPV Xpert detecting HPV 16, 18, 45, 31, 33, 35, 52, 58

Sensitivity Specificity Positive Predictive Value (95% CI) Negative Predictive Value (95% CI) Screen positive (95% CI)
CIN2+
HIV-negative
65 96.4 50.0 (42.3–57.7) 98.0 (96.5–99.5) 6.9 (4.5–9.2)
70 96.4 51.9 (33.3–59.5) 98.3 (97.0–99.7) 7.1 (4.7–9.5)
75 95.3 47.2 (40.2–54.2) 98.6 (97.4–99.8) 8.4 (5.7–11.1)
80 94.1 43.1 (36.7–49.5) 98.8 (97.6–100) 9.8 (6.9–12.8)
85 91.3 35.4 (30.0–40.8) 99.1 (98.1–100) 12.7 (9.3–16.1)
HIV-positive
65 88.3 53.3 (46.6–60.1) 92.5 (89.3–95.7) 20.7 (16.5–25.0)
70 87.2 52.9 (46.4–59.4) 93.4 (90.4–96.4) 22.5 (18.0–27.0)
75 85.8 52.0 (45.8–58.2) 94.4 (91.5–97.3) 24.5 (19.8–29.2)
80 83.2 49.4 (43.5–55.3) 95.3 (92.6–98.0) 27.5 (22.5–32.5)
85 77.0 43.1 (37.8–48.4) 96.2 (93.7–98.7) 33.5 (28.1–39.0)
CIN3+
HIV-negative
65 96.7 39.6 (31.8–47.4) 98.8 (97.7–99.9) 5.3 (3.1–7.4)
70 95.9 36.2 (29.7–43.2) 99.0 (98.0–100) 6.2 (3.8–8.5)
75 95.1 33.7 (27.3–40.1) 99.2 (98.3–100) 7.2 (4.6–9.6)
80 93.4 29.0 (23.4–34.6) 99.4 (98.8–100) 8.9 (6.1–11.8)
85 92.3 28.4 (23.1–33.7) 99.5 (98.8–100) 9.6 (7.1–13.2)
HIV-positive
65 88.4 34.2 (27.7–40.8) 96.5 (94.3–98.7) 16.1 (12.2–20.1)
70 87.1 33.7 (27.5–40.0) 97.0 (95.0–99.0) 17.8 (13.6–21.9)
75 86.1 33.5 (27.5–39.5) 97.4 (95.5–99.3) 19.1 (14.8–23.4)
80 84.8 32.8 (27.1–38.5) 97.9 (96.2–99.6) 20.7 (16.2–25.2)
85 74.8 24.0 (19.7–28.3) 98.3 (96.6–99.9) 30.3 (25.1–35.5)